Length Discrepancy (Total Hip Surgery)

2012 ◽  
pp. 157-157 ◽  
Author(s):  
Augusto Sarmiento
Keyword(s):  
Hip Surgery ◽  
Total Hip ◽  
Length Discrepancy

Changes in patient-perceived leg length discrepancy following total hip arthroplasty

2021 ◽  
Author(s):  
Kentaro Iwakiri ◽  
Yoichi Ohta ◽  
Takashi Fujii ◽  
Yukihide Minoda ◽  
Akio Kobayashi ◽  
...  
Keyword(s):  
Total Hip Arthroplasty ◽  
Hip Arthroplasty ◽  
Leg Length Discrepancy ◽  
Leg Length ◽  
Total Hip ◽  
Length Discrepancy

scholarly journals Intramedullary Bone Lengthening Following Preceding Hip Surgery—A Case Series

2020 ◽  
Vol 9 (12) ◽  
pp. 4104
Author(s):  
Lukas Zak ◽  
Thomas Manfred Tiefenboeck ◽  
Gerald Eliot Wozasek
Keyword(s):  
Hip Dysplasia ◽  
Young Patients ◽  
Limb Lengthening ◽  
Limb Length Discrepancy ◽  
Limb Length ◽  
Hip Surgery ◽  
Bone Lengthening ◽  
Safe Procedure ◽  
Length Discrepancy ◽  
Healing Index

Limb length discrepancy (LLD) is a common problem after joint-preserving hip surgeries, hip dysplasia, and hip deformities. Limping, pain, sciatica, paresthesia, and hip instability are common clinical findings and may necessitate limb-lengthening procedures. The study included five patients (two female and three male, mean age of 28 years (20–49; SD: 12)) with symptomatic limb length discrepancy greater than 2.5 cm (mean: 3.6 cm) after total hip arthroplasty (THA), hip dysplasia, or post-traumatic hip surgery. They underwent either ipsi- or contralateral intramedullary limb-lengthening surgeries using the PRECICE™ telescopic nail. All patients achieved complete bone healing and correction of the pelvic obliquity after intramedullary lengthening. None of the patients had a loss of proximal or distal joint motion. The mean distraction-consolidation time (DCT) was 3.8 months, the distraction index (DI) 0.7 mm/day, the lengthening index (LI) 1.8 months/cm, the consolidation index (CI) 49.2 days/cm, the healing index (HI) 1.1 months/cm, and the modified healing index (HI*) 34 days/cm. Intramedullary limb lengthening after LLD in cases of hip dysplasia, hip deformity, and various kinds of hip surgery is a useful and safe procedure in young patients to achieve equal limb length. No functional impairment of the preceded hip surgery was seen.

Heparin and Factor XaI Levels in Patients Undergoing Hip Surgery

1975 ◽  
Author(s):  
Duncan P. Thomas ◽  
S. Sagar ◽  
V. V. Kakkar
Keyword(s):  
Total Hip Replacement ◽  
Hip Replacement ◽  
Subsequent Development ◽  
Hip Surgery ◽  
Factor X ◽  
Preoperative Level ◽  
Total Hip ◽  
Vein Thrombosis ◽  
The Mean ◽  
Plasma Heparin

Plasma heparin and activated Factor X inhibitor (Xal) levels were measured in 25 patients undergoing total hip replacement. Blood samples were taken before, during and for 5 days after operation. In patients receiving heparin prophylaxis, over 50% of samples taken four hours after a subcutaneous injection of 5,000 units had no detectable plasma heparin; in none of the remaining samples did the level exceed 0.04 units per ml. In patients who developed deep vein thrombosis (DVT) postoperatively, as detected by 125-I-labelled fibrinogen and confirmed by venography, the mean preoperative level of Factor XaI was 73.5% (S. E. M.±6.9). In those patients who did not develop DVT, the mean preoperative level was 101.5% (S. E.M.±4.3) (P > 0.01).It is concluded that a regimen of 5,000 units 8-hour’ly does not give sustained plasma heparin levels after total hip replacement, which may in part explain the reduced effectiveness of low-dose heparin in preventing DVT in patients undergoing hip surgery. Low levels of Factor XaI in the immediate preoperative period correlated well with the subsequent development of thrombosis in these patients.

Sign in / Sign up

Export Citation Format

Share Document